February 1, 2024 Press release - Non-regulatory The first patient has been dosed in Circio’s TG01 triple combination study
November 16, 2023 Press release - Non-regulatory Circio inngår nytt samarbeid i USA for å teste kreftvaksinen TG01 i RAS-mutert kreft
March 20, 2020 Press release - Non-regulatory Impact of corona virus (COVID-19) on Targovax’s operations
March 3, 2020 Press release - Non-regulatory Targovax announces completed enrollment in the ONCOS-102 trial in anti-PD1 refractory melanoma
March 3, 2020 Press release - Non-regulatory Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2019 results, Wednesday 11 March
November 11, 2019 Press release - Non-regulatory Presentation of ONCOS-102 melanoma data at SITC Annual Meeting
October 29, 2019 Press release - Non-regulatory Targovax ASA: Invitation to presentation of Targovax’s third quarter 2019 results, Thursday 7 November
October 9, 2019 Press release - Non-regulatory Targovax selected for oral presentation at Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting
September 24, 2019 Press release - Non-regulatory Targovax announces opening of Oslo University Hospital as site for ONCOS-102 trial in melanoma
July 31, 2019 Press release - Non-regulatory Targovax is invited to present at Solebury Trout European Biotech Investor Day in NYC
June 3, 2019 Press release - Non-regulatory Targovax announces publication of in vivo abscopal effect of ONCOS-102 and Keytruda combination
May 8, 2019 Press release - Non-regulatory Targovax announces completed enrollment of ONCOS-102 trial in mesothelioma
March 19, 2019 Press release - Non-regulatory Targovax is invited to present at Neoantigen Summit Europe, DNB SME Conference and BIO-Europe Spring
March 14, 2019 Press release - Non-regulatory Targovax grants Zelluna Immunotherapy an FTO license to intellectual property relating to mutant RAS T cell receptor technology
March 8, 2019 Press release - Non-regulatory Targovax announces Notice of Allowance in the US on patent covering the TG mutant-RAS neoantigen vaccine platform
February 11, 2019 Press release - Non-regulatory First patient treated in dose expansion cohort of Targovax’s ONCOS-102 trial in melanoma
February 4, 2019 Press release - Non-regulatory Targovax ASA: Announcement of fourth quarter and full year results 2018
January 17, 2019 Press release - Non-regulatory Targovax granted European Patent for mutant-RAS neoantigen platform lead products
November 28, 2018 Press release - Non-regulatory Targovax is invited to present at upcoming investor and industry conferences
October 15, 2018 Press release - Non-regulatory Targovax reports encouraging disease-free survival (DFS) data from TG01 trial in resected pancreatic cancer
November 2, 2016 Press release - Non-regulatory Targovax announces appointment of Oystein Soug as CEO
October 21, 2016 Press release - Non-regulatory Targovax presents ONCOS-102 scientific rationale at the European Society of Gene and Cell Therapy